| Tipo : |
periódico |
| Enlace : |
http://springerlink.metapress.com/content/n00746v52225x085/?p=70164c5121a44089a4de1c0b90389309&pi=9 |
|
| Los equipos de investigación : |
Toronto - Sunnybrook Health Sciences Center |
| Autores : |
Dupuis LL, Lingertat-Walsh K, Walker SE. |
| Título : |
Stability of an extemporaneous oral liquid aprepitant formulation. |
| número : |
Support Care Cancer ; 17, 6: 701-706. 2009 |
|
| Nivel de evidencia : |
|
| La estabilidad física : |
|
| Estabilidad química : |
|
| otros métodos : |
|
| Comentarios : |
|
Lista de la molécula
 Aprepitant
|
 |
 |
 |
 |
250 mg
Emend® |
| OraPlus® / OraSweet® (1:1) |
>> 12.5 ml |
|
23°C |
 |
| 85 |
 |
|
|
|
|
|
250 mg
Emend® |
| OraPlus® / OraSweet® (1:1) |
>> 12.5 ml |
|
4°C |
|
| 90 |
|
|
|
|
 |
|
250 mg
Emend® |
| OraPlus® / OraSweet® (1:1) |
>> 12.5 ml |
|
23°C |
|
| 50 |
|
|
|
|
|
|
250 mg
Emend® |
| OraPlus® / OraSweet® (1:1) |
>> 12.5 ml |
|
4°C |
|
| 90 |
|
|
|
|
|
